2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
https://ard.bmj.com/content/81/1/34
Author: admin-reumatologi
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases
https://ard.bmj.com/content/81/8/1065
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
https://ard.bmj.com/content/early/2023/03/16/ard-2022-223764
EULAR definition of difficult-to-treat rheumatoid arthritis
https://ard.bmj.com/content/80/1/31
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
https://ard.bmj.com/content/early/2022/11/17/ard-2022-223335